Scientists explain that bird flu poses a threat to traditional vaccine manufacturing because the virus kills the very birds that lay the eggs used as a substrate. This vulnerability is being used to justify the development of mRNA, mammalian cell, and insect cell-based alternatives. Penn Medicine claims to have already developed an experimental mRNA bird flu vaccine that protected lab animals for a year.
